Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Many HIV Screening Tests Yield False-Positive Results

By LabMedica International staff writers
Posted on 23 Mar 2010
A positive screening test for human immunodeficiency virus (HIV) means only that there are antibodies present either to HIV or to something that cross-reacts with it. More...
The test does not mean that a person has or will get acquired immunodeficiency syndrome (AIDS).

In many jurisdictions, tests for HIV are required screening for pregnant women. It has been suggested that the entire population be screened for HIV. The rationale is to prevent transmission of the virus by administration of antiretroviral drugs to individuals who receive positive results from the screening tests.

However, people receiving false-positive results from the HIV screening test might not be infected with the virus. However, they will be told that they have acquired immunodeficiency disease (AIDS) and be required to take expensive, toxic drugs for a condition they cannot transmit because they do not have it.

"The problem of false-positive tests applies to all screening tests, not just HIV," stated Jane M. Orient, M.D., executive director of the Association of American Physicians and Surgeons (AAPS; Arlington, VA, USA). "If a population with a very low likelihood of a disease is tested, there will be very few positive tests. But even with an excellent test, a positive is more likely than not to be a false positive."

Dr. Orient added that although the test is a very good for screening blood donors it can do more harm than good if used to screen the entire population.

An article by Henry H. Bauer, Ph.D., professor emeritus of chemistry and science studies, and dean emeritus of arts and sciences at Virginia Polytechnic Institute and State University (Virginia Tech; Blacksburg, VA, USA) appeared in the spring edition of the Journal of American Physicians and Surgeons. It explains the history behind the HIV screening tests, and the reason such a large proportion of them are likely to give false-positive results.

Related Links:
Association of American Physicians and Surgeons
Virginia Polytechnic Institute and State University
Journal of American Physicians and Surgeons




Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
8-Channel Pipette
SAPPHIRE 20–300 µL
Rapid Molecular Testing Device
FlashDetect Flash10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.